Clinical trial
Open-Label Access Protocol of Denosumab for Subjects with Advanced Cancer
To facilitate the access of denosumab for subjects with advanced cancer who have participated in a denosumab phase 3 study until denosumab is approved and available for sale
| Category | Value |
|---|---|
| Study start date | 2011-08-10 |